Thank you, Mr. Chair. So currently, and as the Minister said, we're only halfway through the year, this year, and we are expecting the program for this year to be within budget. And while costs are still significantly being -- are increasing, there's lots of inflation on the cost of drugs and supplies, there is an extra effort in negotiating those product licensing agreements to get us the lower rates for all the products that are being purchased. And it is doing what we want it to do. It's keeping us within budget.

In addition, the rollout of the new program has also done what we expected it to do in that some people will choose not to register for the program because they do have access to other benefits and weren't accessing them previously or realized that the deductible that they needed to pay is more than what they actually need to pay for their drugs on an annual basis. So that is also having a factor in helping us stay within budget. Yeah, so I think that's it for now, Mr. Chair.